Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV004546569 | SCV005042401 | pathogenic | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | ZCCHC8: PP1:Strong, PM2, PS3:Moderate, PS4:Moderate |
OMIM | RCV000856725 | SCV000999269 | pathogenic | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 5 | 2023-05-08 | no assertion criteria provided | literature only | |
Epi- |
RCV000856725 | SCV004697315 | pathogenic | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 5 | 2024-02-20 | no assertion criteria provided | research | In 3 members of a family with telomere-related pulmonary fibrosis and/or bone marrow failure syndrome-5 (PFBMFT5; 618674), we identified a heterozygous c.557C>T p.(P186L) substitution. The variant segregated with affected family members. With Flow FISH we found short telomeres in 2 family members carrying the variant. The family history is similar to the variant reported by Gable et al. (2019) and the variant is identical. The mutation was identified with whole genome sequencing and confirmed with Sanger Sequencing. |